Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John S Witte

Showing results (51-60 of 256) with videos related to

Pageof 26
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 21, 2005
Role of androgen metabolism genes CYP1B1, PSA/KLK3, and CYP11alpha in prostate cancer risk and aggressivenessMine S Cicek, Xin Liu, Graham Casey, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 16, 2004
No association between a tetranucleotide repeat polymorphism of CYP19 and prostate cancerLi Li, Mine S Cicek, Graham Casey, et al.
The Journal of Urology|November 11, 2005
Relationship between body size and prostate cancer in a sibling based case-control studyXin Liu, Benjamin A Rybicki, Graham Casey, et al.
Cancer Causes & Control : CCC|December 17, 2003
Relation of serum insulin-like growth factor-I (IGF-I) and IGF binding protein-3 to risk of prostate cancer (United States)Li Li, Herbert Yu, Fredrick Schumacher, et al.
Genetic Epidemiology|November 25, 2014
Population genetic simulations of complex phenotypes with implications for rare variant association testsLawrence H Uricchio, Raul Torres, John S Witte, et al.
Genetic Epidemiology|March 27, 2013
The impact of improved microarray coverage and larger sample sizes on future genome-wide association studiesKarla J Lindquist, Eric Jorgenson, Thomas J Hoffmann, et al.
BMC Genetics|February 21, 2004
Comparison of missing data approaches in linkage analysisChao Xing, Fredrick R Schumacher, David V Conti, et al.
Genetics|August 15, 2018
Detecting Rare Mutations with Heterogeneous Effects Using a Family-Based Genetic Random Field MethodMing Li, Zihuai He, Xiaoran Tong, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 27, 2015
Replication and heritability of prostate cancer risk variants: impact of population-specific factorsVictor Virlogeux, Rebecca E Graff, Thomas J Hoffmann, et al.
Pharmaceuticals (Basel, Switzerland)|September 12, 2013
Non-Steroidal Anti-Inflammatory Drugs, Variation in Inflammatory Genes, and Aggressive Prostate CancerAdam C Reese, Jill Hardin, Iona Cheng, et al.
Pageof 26

Showing results (51-60 of 256) with videos related to

Sort By:
Pageof 26
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 21, 2005
Role of androgen metabolism genes CYP1B1, PSA/KLK3, and CYP11alpha in prostate cancer risk and aggressivenessMine S Cicek, Xin Liu, Graham Casey, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 16, 2004
No association between a tetranucleotide repeat polymorphism of CYP19 and prostate cancerLi Li, Mine S Cicek, Graham Casey, et al.
The Journal of Urology|November 11, 2005
Relationship between body size and prostate cancer in a sibling based case-control studyXin Liu, Benjamin A Rybicki, Graham Casey, et al.
Cancer Causes & Control : CCC|December 17, 2003
Relation of serum insulin-like growth factor-I (IGF-I) and IGF binding protein-3 to risk of prostate cancer (United States)Li Li, Herbert Yu, Fredrick Schumacher, et al.
Genetic Epidemiology|November 25, 2014
Population genetic simulations of complex phenotypes with implications for rare variant association testsLawrence H Uricchio, Raul Torres, John S Witte, et al.
Genetic Epidemiology|March 27, 2013
The impact of improved microarray coverage and larger sample sizes on future genome-wide association studiesKarla J Lindquist, Eric Jorgenson, Thomas J Hoffmann, et al.
BMC Genetics|February 21, 2004
Comparison of missing data approaches in linkage analysisChao Xing, Fredrick R Schumacher, David V Conti, et al.
Genetics|August 15, 2018
Detecting Rare Mutations with Heterogeneous Effects Using a Family-Based Genetic Random Field MethodMing Li, Zihuai He, Xiaoran Tong, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 27, 2015
Replication and heritability of prostate cancer risk variants: impact of population-specific factorsVictor Virlogeux, Rebecca E Graff, Thomas J Hoffmann, et al.
Pharmaceuticals (Basel, Switzerland)|September 12, 2013
Non-Steroidal Anti-Inflammatory Drugs, Variation in Inflammatory Genes, and Aggressive Prostate CancerAdam C Reese, Jill Hardin, Iona Cheng, et al.
Pageof 26